| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.81B | 7.85B | 6.48B | 5.78B | 4.71B | 4.59B |
| Gross Profit | 3.85B | 3.02B | 2.53B | 2.22B | 1.93B | 1.99B |
| EBITDA | 3.50B | 2.78B | 2.40B | 2.04B | 1.71B | 1.53B |
| Net Income | 957.98M | 951.68M | 340.09M | 141.21M | 336.14M | 978.84M |
Balance Sheet | ||||||
| Total Assets | 59.50B | 51.04B | 44.01B | 37.89B | 34.91B | 32.48B |
| Cash, Cash Equivalents and Short-Term Investments | 6.81B | 3.51B | 1.99B | 631.68M | 269.26M | 1.55B |
| Total Debt | 18.16B | 16.76B | 16.12B | 14.96B | 14.68B | 14.22B |
| Total Liabilities | 20.48B | 18.47B | 17.64B | 16.50B | 15.91B | 15.26B |
| Stockholders Equity | 38.76B | 31.96B | 25.40B | 20.29B | 17.64B | 15.97B |
Cash Flow | ||||||
| Free Cash Flow | 2.77B | 2.20B | 1.55B | 1.30B | 1.26B | 1.35B |
| Operating Cash Flow | 2.79B | 2.26B | 1.60B | 1.33B | 1.28B | 1.36B |
| Investing Cash Flow | -7.26B | -5.51B | -5.71B | -3.70B | -4.52B | 2.35B |
| Financing Cash Flow | 7.56B | 4.91B | 5.45B | 2.76B | 1.57B | -2.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $13.51B | 25.69 | 11.28% | 5.86% | 13.50% | 31.56% | |
78 Outperform | $8.42B | 28.09 | 8.13% | 3.44% | 59.25% | 88.37% | |
77 Outperform | $140.22B | 153.99 | 2.78% | 1.38% | 32.27% | 67.00% | |
74 Outperform | $4.81B | 26.52 | 6.29% | 6.22% | 8.12% | 75.95% | |
68 Neutral | $38.79B | 152.35 | 2.15% | 2.34% | 15.69% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
59 Neutral | $12.08B | ― | -0.48% | 6.57% | 9.58% | -111.99% |
On October 28, 2025, Welltower Inc. announced a new equity distribution agreement allowing for the sale of up to $7.5 billion in common stock through various sales agents. This move, which replaces a previous agreement from March 2025, is part of Welltower’s strategy to manage its capital structure and potentially fund future acquisitions. Additionally, Welltower filed prospectus supplements with the SEC to register the resale of shares issued for recent acquisitions and the possible issuance of shares related to redemption of OP Units, indicating ongoing strategic financial maneuvers to support its growth and operational flexibility.
On October 27, 2025, Welltower Inc. announced the adoption of a Ten-Year Executive Continuity and Alignment Program, aimed at securing its senior leadership team and aligning their interests with shareholders. This program includes a long-term equity-based incentive structure for its executives, with a focus on achieving market capitalization and total shareholder return milestones. The initiative is expected to drive long-term shareholder returns and reinforce Welltower’s position as a leader in the healthcare REIT sector, particularly as it intensifies its focus on seniors housing and technology-driven operational excellence.
On October 27, 2025, Welltower Inc. announced its third-quarter results, highlighting a 20.7% increase in normalized funds from operations and a 14.5% growth in same-store NOI, driven by strong performance in its Seniors Housing Operating portfolio. The company completed $1.9 billion in investments and announced $23 billion in transaction activities, including significant acquisitions in the U.S. and U.K., which are expected to enhance its market position and growth potential. Additionally, Welltower introduced a Ten Year Executive Continuity and Alignment Program to secure its leadership team, aiming for long-term stability and alignment with shareholder interests.